KODIAK SCIENCES INC. Increase (Decrease) in Accounts Payable
KODIAK SCIENCES INC. (KOD) reported Increase (Decrease) in Accounts Payable of $249.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $982.00K.
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$733.00K, a 128.13% decline year-over-year.
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.63M, a 155.26% increase year-over-year.
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $5.32M, a 235.54% increase year-over-year.
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for fiscal 2025 was $8.07M.
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for fiscal 2024 was -$9.69M, a 273.18% decline from fiscal 2023.
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for fiscal 2023 was $5.60M, a 237.17% increase from fiscal 2022.
- KODIAK SCIENCES INC. increase (decrease) in accounts payable for fiscal 2022 was $1.66M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $982.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $249.00K 10-Q · filed 2026-08-13 | $1.88M derived: sum of 3 quarters · filed 2026-08-13 | $7.19M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$733.00K 10-Q · filed 2026-05-07 | $893.00K derived: sum of 2 quarters · filed 2026-05-07 | $6.21M derived: sum of 3 quarters · filed 2026-05-07 | $4.73M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $6.94M derived: sum of 2 quarters · filed 2026-03-31 | $5.46M derived: sum of 3 quarters · filed 2026-08-13 | $8.07M 10-K · filed 2026-03-31 |
| 2025-09-30 | $5.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.84M derived: sum of 2 quarters · filed 2026-08-13 | $6.44M 10-Q · filed 2025-11-13 | $7.08M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.13M 10-Q · filed 2026-08-13 | $1.77M derived: sum of 3 quarters · filed 2026-08-13 | $3.35M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.61M 10-Q · filed 2026-05-07 | $3.24M derived: sum of 2 quarters · filed 2026-05-07 | $4.83M derived: sum of 3 quarters · filed 2026-05-07 | $4.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.22M derived: sum of 2 quarters · filed 2026-03-31 | $1.43M derived: sum of 3 quarters · filed 2026-03-31 | -$9.69M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $793.00K derived: sum of 2 quarters · filed 2025-11-13 | -$10.33M 10-Q · filed 2025-11-13 | -$7.85M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-06-30 | -$791.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$11.91M 10-Q · filed 2025-08-13 | -$9.43M derived: sum of 3 quarters · filed 2026-03-31 | -$9.87M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-03-31 | -$11.12M 10-Q · filed 2025-05-14 | -$8.64M derived: sum of 2 quarters · filed 2026-03-31 | -$9.07M derived: sum of 3 quarters · filed 2026-03-31 | -$3.63M derived: sum of 4 quarters · filed 2026-03-31 |
| 2023-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.05M derived: sum of 2 quarters · filed 2026-03-31 | $7.50M derived: sum of 3 quarters · filed 2026-03-31 | $5.60M 10-K · filed 2026-03-31 |
| 2023-09-30 | -$435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $5.01M derived: sum of 2 quarters · filed 2024-11-14 | $3.11M 10-Q · filed 2024-11-14 | -$2.31M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | $5.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $3.55M 10-Q · filed 2024-08-14 | -$1.88M derived: sum of 3 quarters · filed 2025-03-27 | -$7.66M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-03-31 | -$1.90M 10-Q · filed 2024-05-15 | -$7.33M derived: sum of 2 quarters · filed 2025-03-27 | -$13.10M derived: sum of 3 quarters · filed 2025-03-27 | -$6.75M derived: sum of 4 quarters · filed 2025-03-27 |
| 2022-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$11.20M derived: sum of 2 quarters · filed 2025-03-27 | -$4.84M derived: sum of 3 quarters · filed 2025-03-27 | $1.66M 10-K · filed 2025-03-27 |
| 2022-09-30 | -$5.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $584.00K derived: sum of 2 quarters · filed 2023-11-14 | $7.09M 10-Q · filed 2023-11-14 | $1.74M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $12.86M 10-Q · filed 2023-08-14 | $7.51M derived: sum of 3 quarters · filed 2024-03-28 | $16.52M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $6.50M 10-Q · filed 2023-05-15 | $1.16M derived: sum of 2 quarters · filed 2024-03-28 | $10.16M derived: sum of 3 quarters · filed 2024-03-28 | $4.58M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | -$5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.66M derived: sum of 2 quarters · filed 2024-03-28 | -$1.93M derived: sum of 3 quarters · filed 2024-03-28 | -$2.09M 10-K · filed 2024-03-28 |
| 2021-09-30 | $9.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.42M derived: sum of 2 quarters · filed 2022-11-09 | $3.25M 10-Q · filed 2022-11-09 | $6.86M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | -$5.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$5.75M 10-Q · filed 2022-08-09 | -$2.15M derived: sum of 3 quarters · filed 2023-03-28 | -$4.87M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | -$165.00K 10-Q · filed 2022-05-10 | $3.44M derived: sum of 2 quarters · filed 2023-03-28 | $721.00K derived: sum of 3 quarters · filed 2023-03-28 | $3.17M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $886.00K derived: sum of 2 quarters · filed 2023-03-28 | $3.34M derived: sum of 3 quarters · filed 2023-03-28 | $5.22M 10-K · filed 2023-03-28 |
| 2020-09-30 | -$2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$271.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.62M 10-Q · filed 2021-11-09 | $2.56M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.34M 10-Q · filed 2021-08-09 | $5.29M derived: sum of 3 quarters · filed 2022-03-01 | $4.57M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.89M 10-Q · filed 2021-05-10 | $2.84M derived: sum of 2 quarters · filed 2022-03-01 | $2.11M derived: sum of 3 quarters · filed 2022-03-01 | $2.86M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $227.00K derived: sum of 2 quarters · filed 2022-03-01 | $975.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.57M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$722.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $26.00K derived: sum of 2 quarters · filed 2020-11-09 | $620.00K 10-Q · filed 2020-11-09 | $51.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $748.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.34M 10-Q · filed 2020-08-10 | $773.00K derived: sum of 3 quarters · filed 2021-03-01 | $864.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $594.00K 10-Q · filed 2020-05-11 | $25.00K derived: sum of 2 quarters · filed 2021-03-01 | $116.00K derived: sum of 3 quarters · filed 2021-03-01 | -$346.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$569.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$478.00K derived: sum of 2 quarters · filed 2021-03-01 | -$940.00K derived: sum of 3 quarters · filed 2021-03-01 | -$2.32M 10-K · filed 2021-03-01 |
| 2018-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$371.00K derived: sum of 2 quarters · filed 2019-11-12 | -$1.75M 10-Q · filed 2019-11-12 | -$1.49M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -$462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$1.84M 10-Q · filed 2019-08-14 | -$1.58M derived: sum of 3 quarters · filed 2020-03-16 | |
| 2018-03-31 | -$1.38M 10-Q · filed 2019-05-15 | -$1.12M derived: sum of 2 quarters · filed 2020-03-16 | ||
| 2017-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.28M 10-K · filed 2020-03-16 | ||
| 2017-09-30 | $2.02M 10-Q · filed 2018-11-16 | |||
| 2016-12-31 | $23.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |